HealthCor Partners has been an investor since 2007 and is a significant shareholder of Paradigm Spine. Jeff Lightcap, Senior Managing Director at HealthCor and a member of the Paradigm Board said "HealthCor has watched the compelling value proposition of Paradigm Spine increase over the past few years, from a small, R&D focused product development company to an established operational business with a full product portfolio. We believe this financing will take the Company even further to the next level, enabling achievement of significant sales, clinical and regulatory milestones in the next few years."
Paradigm Spine is also pleased to announce the promotion of Matt Stuttle to the position of Vice President, US Sales. Matt joined Paradigm Spine in June of 2008 as an Area Sales Director for the Western US with over 12 years of Pharmaceutical and Medical Device experience. He has held various positions in Sales, Sales Management, and Director level roles with Forest Pharmaceuticals, Kyphon, and most recently Medtronic Spine and Biologics.
"Promoting Matt to Vice President, US Sales, creates a results oriented culture and strong foundation for our US Sales team," commented Chris Hughes, President, US. "He will continue to add extensive industry knowledge, surgeon and sales force relationships to the US infrastructure, and he will be instrumental in strategically executing our US sales plan."
About Paradigm Spine, LLC
Paradigm Spine is a company focused on the design, development and marketing of innovative non-fusion solutions for the treatment of spinal conditions and diseases. The company's mission is to provide only "Best in Class" products and services to Spine Surgeons and to be above all, "Surgeon Centric, Indication Specific and Data Driven".
The company is concentrating on building a multi-product non-fusion por
|SOURCE Paradigm Spine, LLC|
Copyright©2009 PR Newswire.
All rights reserved